Patents

US 12285427 B2: Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL selective inhibitor

Granted
2025-04-29
Filed
2023-08-07 application 18215731
Type
Utility · 4 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

This invention establishes a new paradigm for treatment of Parkinson's disease (PD) by eliminating senescent cells that reside in or around the site of the disease pathophysiology. Exposure of test subjects to the herbicide paraquat (PQ) increases the risk for developing Parkinson's disease. The data in this disclosure show that PQ induces a senescence arrest and SASP in astrocytes, in culture and in vivo in mice, and senescent cell markers were present in astrocytes in midbrain tissue from PD patients. In a transgenic mouse model, senescent cell ablation protected against PQ-induced PD-like neuropathology. Removal of senescent cells from affected sites using small molecule agents that specifically target senescent cells can help prevent or ameliorate signs and symptoms of the disease.

Source: PVGPATDIS, file of 2026-04-10 (ipg250429.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Unity Biotechnology, Inc. 41 patentsUS company or organizationSouth San Francisco, CAUnity Biotechnology, Inc. Form D issuer EXACT high confidence: identical full name and state
UNITY BIOTECHNOLOGY, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10
Mayo Foundation for Medical Education and Research 1,349 patentsUS company or organizationRochester, MNPVGPATDIS, file of 2026-04-10
BUCK INSTITUTE FOR RESEARCH ON AGING 52 patentsUS company or organizationNovato, CABUCK INSTITUTE FOR RESEARCH ON AGING Nonprofit EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Remi-Martin LabergeSouth San Francisco, CA24PVGPATDIS, file of 2026-04-10
Judith CampisiBerkeley, CA24PVGPATDIS, file of 2026-04-10
Marco DemariaSan Francisco, CA20PVGPATDIS, file of 2026-04-10
Bennett G. ChildsRochester, MN9PVGPATDIS, file of 2026-04-10
Jan M.A. van DeursenRochester, MN15PVGPATDIS, file of 2026-04-10
Nathaniel DavidSouth San Francisco, CA41PVGPATDIS, file of 2026-04-10
Alain P. VasserotSouth San Francisco, CA82PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/496PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P9/10PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/0081PVGPATDIS, file of 2026-04-10
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms ; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processesC12Q1/485PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-06-07Assignment
Assignment of assignor's interest
DAVID, NATHANIEL signed 2016-08-02
VASSEROT, ALAIN PHILIPPE signed 2016-08-02
UNITY BIOTECHNOLOGY, INC. SOUTH SAN FRANCISCO, CA67658/807ECORSEXC, file of 2026-09-25
2024-06-07Assignment
Assignment of assignor's interest
KIRKLAND, JAMES L. signed 2016-09-09
TCHKONIA, TAMAR signed 2016-09-09
BAKER, DARREN J. signed 2016-09-15
CHILDS, BENNETT G. signed 2016-09-15
VAN DEURSEN, JAN M.A. signed 2016-09-23
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH ROCHESTER, MN67658/801ECORSEXC, file of 2026-09-25
2024-06-07Assignment
Assignment of assignor's interest
DEMARIA, MARCO signed 2016-08-02
LABERGE, REMI-MARTIN signed 2016-08-02
CAMPISI, JUDITH signed 2016-08-03
DAVALOS, ALBERT signed 2016-08-03
BUCK INSTITUTE FOR RESEARCH ON AGING NOVATO, CA67658/795ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.